Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 5, 2025 • 7:00 PM ET

Date/Time Source News Release
03/27/2025 04:10 PM EDT GlobeNewswire Tempest Reports Year End 2024 Financial Results and Provides Business Update
03/25/2025 04:30 PM EDT GlobeNewswire Tempest Announces Amezalpat Poster Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting
03/13/2025 08:00 AM EDT GlobeNewswire FDA Study May Proceed Notice Received for Phase 2 Trial of TPST-1495 for the Treatment of Familial Adenomatous Polyposis (FAP)
02/10/2025 08:00 AM EST GlobeNewswire Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma
02/07/2025 04:30 PM EST GlobeNewswire Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01/06/2025 08:00 AM EST GlobeNewswire Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC)
12/06/2024 04:30 PM EST GlobeNewswire Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/25/2024 04:30 PM EST GlobeNewswire Tempest to Participate in the Piper Sandler 36th Annual Healthcare Conference
11/12/2024 04:21 PM EST GlobeNewswire Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update
11/12/2024 08:00 AM EST GlobeNewswire Tempest Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy for the Treatment of First-Line Hepatocellular Carcinoma
Page

Additional News

As of April 5, 2025 • 7:00 PM ET

Date/Time Source News Release
03/27/2025 04:52 PM EDT SeekingAlpha Tempest Therapeutics GAAP EPS of -$1.50 misses by $0.15
03/25/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, March 25th, 2025
03/25/2025 05:31 AM EDT US Earnings Reports Expected earnings - Tempest Therapeutics Inc.
03/18/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, March 18th, 2025
03/18/2025 05:31 AM EDT US Earnings Reports Expected earnings - Tempest Therapeutics Inc.
02/10/2025 08:26 AM EST SeekingAlpha Tempest gets fast track designation from FDA for amezalpat
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Tempest Therapeutics Inc.
11/12/2024 05:49 PM EST SeekingAlpha Tempest Therapeutics GAAP EPS of -$0.41 misses by $0.05
10/16/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Wed, Oct 16, 2024 as of 10.00 am ET
10/10/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Thu, Oct 10, 2024 as of 10.00 am ET
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.